These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 2288861
21. An assessment of the sensitivity of in vivo 31P nuclear magnetic resonance spectroscopy as a means of detecting pH heterogeneity in tumours: a simulation study. Madden A, Glaholm J, Leach MO. Br J Radiol; 1990 Feb; 63(746):120-4. PubMed ID: 2310904 [Abstract] [Full Text] [Related]
22. In vivo 31P nuclear magnetic resonance spectroscopy of experimental murine tumours and human tumour xenografts: effects of blood flow modification. Bremner JC, Counsell CJ, Adams GE, Stratford IJ, Wood PJ, Dunn JF, Radda GK. Br J Cancer; 1991 Nov; 64(5):862-6. PubMed ID: 1931606 [Abstract] [Full Text] [Related]
23. Tumor 31P NMR pH measurements in vivo: a comparison of inorganic phosphate and intracellular 2-deoxyglucose-6-phosphate as pHnmr indicators in murine radiation-induced fibrosarcoma-1. Soto GE, Zhu Z, Evelhoch JL, Ackerman JJ. Magn Reson Med; 1996 Nov; 36(5):698-704. PubMed ID: 8916020 [Abstract] [Full Text] [Related]
24. Effects of oxygen on the metabolism of murine tumors using in vivo phosphorus-31 NMR. Okunieff P, McFarland E, Rummeny E, Willett C, Hitzig B, Neuringer L, Suit H. Am J Clin Oncol; 1987 Dec; 10(6):475-82. PubMed ID: 3687832 [Abstract] [Full Text] [Related]
25. Magnetic resonance spectroscopic studies on 'real-time' changes in RIF-1 tumour metabolism and blood flow during and after photodynamic therapy. Bremner JC, Bradley JK, Stratford IJ, Adams GE. Br J Cancer; 1994 Jun; 69(6):1083-7. PubMed ID: 8198974 [Abstract] [Full Text] [Related]
26. Magnetic resonance imaging and spectroscopy of combretastatin A4 prodrug-induced disruption of tumour perfusion and energetic status. Beauregard DA, Thelwall PE, Chaplin DJ, Hill SA, Adams GE, Brindle KM. Br J Cancer; 1998 Jun; 77(11):1761-7. PubMed ID: 9667644 [Abstract] [Full Text] [Related]
27. 31P-Nuclear magnetic resonance spectroscopy of rat pituitary tumours in vivo. Prysor-Jones RA, Silverlight JJ, Jenkins JS, Stevens AN, Rodrigues JL, Griffiths JR. J Endocrinol; 1985 Sep; 106(3):349-53. PubMed ID: 4045341 [Abstract] [Full Text] [Related]
28. Energy metabolism, pH changes, and lactate production in RIF-1 tumors following intratumoral injection of glucose. Bhujwalla ZM, Constantinidis I, Chatham JC, Wehrle JP, Glickson JD. Int J Radiat Oncol Biol Phys; 1992 Sep; 22(1):95-101. PubMed ID: 1727132 [Abstract] [Full Text] [Related]
29. Cellular energetics measured by phosphorous nuclear magnetic resonance spectroscopy are not correlated with chronic nutrient deficiency in multicellular tumor spheroids. Freyer JP, Schor PL, Jarrett KA, Neeman M, Sillerud LO. Cancer Res; 1991 Aug 01; 51(15):3831-7. PubMed ID: 1855200 [Abstract] [Full Text] [Related]
30. An assessment of 31P MRS as a method of measuring pH in rat tumours. Stubbs M, Bhujwalla ZM, Tozer GM, Rodrigues LM, Maxwell RJ, Morgan R, Howe FA, Griffiths JR. NMR Biomed; 1992 Aug 01; 5(6):351-9. PubMed ID: 1489671 [Abstract] [Full Text] [Related]
31. Phosphorus nuclear magnetic resonance study of the rat kidney in vivo. Balaban RS, Gadian DG, Radda GK. Kidney Int; 1981 Nov 01; 20(5):575-9. PubMed ID: 7343707 [Abstract] [Full Text] [Related]
32. Correlations between in vivo 31P NMR spectroscopy measurements, tumor size, hypoxic fraction and cell survival after radiotherapy. Fu KK, Wendland MF, Iyer SB, Lam KN, Engeseth H, James TL. Int J Radiat Oncol Biol Phys; 1990 Jun 01; 18(6):1341-50. PubMed ID: 2370183 [Abstract] [Full Text] [Related]
33. Reduction of tumour intracellular pH and enhancement of melphalan cytotoxicity by the ionophore Nigericin. Wood PJ, Sansom JM, Newell K, Tannock IF, Stratford IJ. Int J Cancer; 1995 Jan 17; 60(2):264-8. PubMed ID: 7829226 [Abstract] [Full Text] [Related]
34. In vivo and in vitro 31P-NMR preliminary studies of the VX-2 carcinoma in rabbits. Mills P, Buonomo C, Pillai RP, Samphilipo MA, Rajan SS, Strandberg JD, Anderson JH. Invest Radiol; 1988 Aug 17; 23(8):584-91. PubMed ID: 3417436 [Abstract] [Full Text] [Related]
35. Tumor size dependent changes in a murine fibrosarcoma: use of in vivo 31P NMR for non-invasive evaluation of tumor metabolic status. Okunieff PG, Koutcher JA, Gerweck L, McFarland E, Hitzig B, Urano M, Brady T, Neuringer L, Suit HD. Int J Radiat Oncol Biol Phys; 1986 May 17; 12(5):793-9. PubMed ID: 3710861 [Abstract] [Full Text] [Related]
36. Growth studies of subcutaneous rat tumours: comparison of 31P-NMR spectroscopy, acid extracts and histology. Stubbs M, Rodrigues LM, Griffiths JR. Br J Cancer; 1989 Nov 17; 60(5):701-7. PubMed ID: 2803946 [Abstract] [Full Text] [Related]
37. Interaction of oxygen partial pressure and energy metabolism with the relaxation rate of inorganic phosphate: a 31P NMR study. Okunieff P, Tokuhiro T, Vaupel P, Neuringer LJ. Adv Exp Med Biol; 1990 Nov 17; 277():95-105. PubMed ID: 2096692 [No Abstract] [Full Text] [Related]
38. [Evaluation of thermal damage after hyperthermia on murine experimental tumor by 31P-NMR spectroscopy--correlation between ATP and growth curve]. Kitada N, Akagi K, Uda M, Hasegawa T, Oshima T, Tanaka Y. Nihon Igaku Hoshasen Gakkai Zasshi; 1992 May 25; 52(5):669-73. PubMed ID: 1508639 [Abstract] [Full Text] [Related]
39. The effect of intra-tumour heterogeneity on the distribution of phosphorus-containing metabolites within human breast tumours: an in vitro study using 31P NMR spectroscopy. Smith TA, Glaholm J, Leach MO, Machin L, McCready VR. NMR Biomed; 1991 Dec 25; 4(6):262-7. PubMed ID: 1667849 [Abstract] [Full Text] [Related]
40. Response of radiation-induced fibrosarcoma-1 in mice to cyclophosphamide monitored by in vivo 31P nuclear magnetic resonance spectroscopy. Li SJ, Wehrle JP, Rajan SS, Steen RG, Glickson JD, Hilton J. Cancer Res; 1988 Sep 01; 48(17):4736-42. PubMed ID: 3409214 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]